HIV drugs found to significantly reduce Alzheimer's risk in new study

HIV drugs offer 'substantial' Alzheimer's protection, new research indicates

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

Texas A&M Health's DARI symposium ramps up collaboration on dementia and Alzheimer's

Texas A&M's Dementia and Alzheimer's Research Initiative hosted its inaugural symposium Wednesday and brought faculty and staff from several disciplines together to work on battling the disorder.

Some Medications Used to Treat HIV May Prevent or Delay Alzheimer’s Onset

While investigating how the medicine uses the body’s immune system to ward off HIV symptoms, researchers realized that it could also be applied to Alzheimer’s disease.

HIV drugs found to significantly reduce Alzheimer's risk in new study

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially less likely to develop the memory-robbing condition.

HIV drugs offer 'substantial' Alzheimer's protection, new research suggests

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially less likely to develop the condition. The researchers have published their findings in Alzheimer's & Dementia.

HIV Drugs Show Surprising Shield Against Alzheimer's

A common medication used to treat HIV and hepatitis B may offer unexpected protection against Alzheimer's disease. The post HIV Drugs Show Surprising Shield Against Alzheimer’s appeared first on Study Finds.